Is Longeveron LLC (LGVN) overvalued? · rev $2.4M
Longeveron LLC (LGVN) is a biotechnology company listed on NASDAQ.
This page asks whether Longeveron LLC (LGVN) looks expensive on cached numbers — not a short thesis.
Latest reported LGVN revenue for 2024-12-31 was $2.4M. Net income was -$16.0M. Revenue was up 237.4% from 2023-12-31 to 2024-12-31. LGVN currently screens at market cap $26.5M.
LGVN currently screens at market cap $26.5M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next LGVN 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the LGVN stock page for the full model, not this heading.
Not investment advice.